Healthcare -
Biotechnology - NASDAQ - US
$ 115.69
1.08 %
$ 11.1 B
Market Cap
75.12
P/E
SRPT - STOCK-BASED COMPENSATION
Stock-based Compensation SRPT - Sarepta Therapeutics, Inc.
183 M
LAST VALUE
26.56%
2 YEAR CAGR
29.49%
5 YEAR CAGR
32.28%
10 YEAR CAGR